Тикагрелор Тева

Тикагрелор Тева is an oral antiplatelet medication used to reduce the risk of blood clots in patients with heart conditions. It belongs to the P2Y12 inhibitor class and is prescribed to support cardiovascular health. This generic version is manufactured by Teva B.V. in the EU.

Тикагрелор Тева is primarily used to prevent blood clots in people with acute coronary syndromes or a history of heart attack. It works by inhibiting platelet activation, helping to maintain healthy blood flow. This medication is often prescribed alongside aspirin for enhanced cardiovascular support. Patients may wonder, what is тикагрелор тева used for in daily heart health management?

Тикагрелор Тева helps maintain normal blood flow by reducing the tendency of platelets to clump together. Users may experience improved circulation and reduced risk of clot-related events. Common effects include mild headache or dizziness as the body adjusts. These effects are generally temporary and vary by individual.

Тикагрелор Тева should be taken exactly as prescribed by a healthcare provider. Avoid sudden discontinuation without medical advice, as this may increase clot risk. Patients with active bleeding conditions should use this medication with caution. Always inform your doctor about current medications and health conditions before starting тикагрелор тева.

Тикагрелор Тева may interact with other blood thinners, NSAIDs, or certain antidepressants. Grapefruit and its juice can affect how the medication works, so consumption should be limited. Strong CYP3A4 inhibitors or inducers may alter тикагрелор тева levels in the body. Alcohol use should be discussed with a healthcare provider due to potential bleeding risks.